Hui Xu Zhang

Dr. Hui Xu Zhang


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2015 in International Journal of Computer Assisted Radiology and Surgery
Verified
Journal Article
Closed access
PDF file
DWDongwen Wang
Dongwen Wang
BZBin Zhang
Bin Zhang
XYXiaobin Yuan
Xiaobin Yuan
HZHui Xu Zhang
Hui Xu Zhang
CLChen Liu
Chen Liu

1 July 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
WYWeitao Yao
Weitao Yao
XWXin Wei
Xin Wei
QJQiang Jing
Qiang Jing
XYXiaobin Yuan
Xiaobin Yuan
FLFan Liu
Fan Liu
HZHui Xu Zhang
Hui Xu Zhang
Background: One of the most prevalent urinary disorders worldwide, urolithiasis has symptoms and a high rate of recurrence. It has placed a significant strain on the global economy and health care system, particularly among those aged 20–54. Comprehensive research on the global burden and evolving trends of urinary calculi in the 20–54 age range is lacking. Methods: Three important urolithiasis indicators—prevalence, incidence, and Disability-Adjusted Life Years (DALYs)—were used from the Global Burden of Disease (GBD) database between 1990 and 2021 for this study.Point estimates were provided, as well as 95% uncertainty intervals (UIs).. To assess trends in the burden of urolithiasis among the 20–54 age range, we used percentage change and estimated annual percentage change (EAPC). The time trends from 1990 to 2021 were thoroughly examined using joinpoint regression analysis. This method makes it possible to compute the annual percent change (APC) and average annual percent change (AAPC), as well as the 95% Confidence Intervals (CIs)that go with them. Results: The number of patients, cases, and DALYs linked to urinary stones among people aged 20–54 has significantly increased worldwide. For example, the number of urolithiasis cases increased by 48%, from 1,576,704 in 1990–2,335,010 in 2021. Comparably, the number of new cases increased by 47%, from 42,272,855 in 1990–62,269,033 in 2021. Between 1990 and 2021, the number of DALYs rose from 218,150–290,210, representing a roughly 33% increase. As of 2021, intermediate sociodemographic index (SDI) regions had the highest DALY rates, while medium-high SDI regions had the highest prevalence and incidence rates among the five SDI regions examined for this time period. Individuals between the ages of 50–54 had the greatest incidence rate within the designated cohort for that year, followed by those between the ages of 45–49 and 40–44. Across all age groups, there were noticeable gender differences, with males showing significantly greater rates than girls. Conclusions: Overall, over the past 32 years, the prevalence of urolithiasis among people aged 20–54 has increased dramatically worldwide, especially in low-SDI nations and among those aged 50–54. With the goal of reducing the social and medical cost and enhancing the working-age population’s quality of life and productivity, the study’s findings highlight the urgent need for focused intervention techniques to prevent and treat urolithiasis in this age group. For example, in middle – high SDI areas, encourage 3 liters of water and a low – salt diet daily, especially for the over - 50s. In middle SDI areas, enhance primary care diagnostics, like using portable ultrasound. Regular screenings should be set for males in high – risk jobs, such as heat – exposed ones. However, this GBD – based study has limitations like data uncertainty, insufficient local strategies, and lack of trend tracking.

18 July 2024 in BMC Urology
Verified
Journal Article
Open access
PDF file
QJQiang Jing
Qiang Jing
FLFan Liu
Fan Liu
XYXiaobin Yuan
Xiaobin Yuan
HZHui Xu Zhang
Hui Xu Zhang
XCXiaoming Cao
Xiaoming Cao
Objectives: To compare the clinical efficacy and safety of single-use and reusable digital flexible ureteroscopy for the treatment of lower pole stones. Methods: We enrolled 135 patients underwent reusable flexible ureteroscopy (FURS) and 78 patients underwent single-use digital FURS. Demographic, clinical variables, anatomical parameters of the lower calyx and perioperative indicators were compared in the two groups. Results: Thirty-six patients in the infundibuloureter angle (IPA) < 45° subgroup had a mini-percutaneous nephrolithotomy (mini-PCNL), including 25 patients in the reusable FURS group and 11 patients in the single-use FURS group. The demographic and clinical variables in the two FURS groups were comparable. There was no statistical difference in the success rate of stone searching (P > 0.05). In terms of the success rate of lithotripsy, there was also no statistical difference in the IPA ≥ 45° subgroup (P > 0.05), whereas single-use FURS was superior in the IPA < 45° subgroup (χ2 = 6.513, P = 0.011). The length of the working fiber in the reusable FURS and single-use FURS groups was 3.20 ± 0.68 mm and 1.75 ± 0.47 mm, respectively (t = 18.297, P < 0.05). The use of a stone basket in the reusable FURS (31/135, 23.0%) was significantly higher than that in the single-use FURS (8/78, 10.3%) (χ2 = 5.336, P = 0.021). Compared with the reusable FURS group, the single-use FURS group had shorter operation times (P < 0.05) and higher stone-free rate (SFR) (χ2 = 4.230, P = 0.040). There was no statistical difference in the intraoperative transfer of mini-PCNL and postoperative complications between the two groups (P > 0.05). Conclusions: Single-use and reusable FURS are alternative methods for removal of lower pole stones (i.e., 2 cm or less). Single-use FURS has a high success rate of lithotripsy, shorter operation time, and high stone-free rate.

18 February 2022 in Frontiers in Pharmacology
Verified
Journal Article
Open access
LLLimin Liao
Limin Liao
QLQinggang Liu
Qinggang Liu
HCHuiling Cong
Huiling Cong
ZXZhihui Xu
Zhihui Xu
ELEnhui Li
Enhui Li
JDJinkai Dong
Jinkai Dong
Objective: To evaluate the efficacy and safety of Hengli® Chinese botulinum toxin type A (BTX-A; 100 U) in Chinese patients with overactive bladder.Methods: This study was a multicenter, randomized, double-blind, placebo-controlled trial in Chinese patients who were inadequately managed with anticholinergic medications. Eligible patients were randomized 2:1 to receive intradetrusor injections of Hengli® BTX-A (n = 144) or placebo (n = 72). The primary endpoint was the change in the number of daily micturition episodes at week 6 from baseline. The secondary efficacy endpoints included the average frequency of urgency and urinary incontinence (UI) episodes per day, urgency score, average micturition volume per day, OABSS, and QoL score.Results: In the Hengli® BTX-A group, there was a significantly greater reduction in the average number of micturition episodes per 24 h compared with the placebo group (3.28 vs. 1.43; p = 0.003). Moreover, there was a significantly greater improvement in the daily number of urgency episodes, micturition volume and OABSS score. An increased post-void residual urine volume, dysuria, and urinary tract infection represented adverse events (AEs) in the Hengli® BTX-A group. Most AEs were mild or moderate in severity. One patient in the BTX-A group initiated clean intermittent catheterization (CIC) during treatment.Conclusion: Hengli® BTX-A treatment was well-tolerated and resulted in significant improvements in OAB symptoms among Chinese patients inadequately managed by anticholinergics.Clinical Trial Registration:http://www.chinadrugtrials.org.cn/clinicaltrials.prosearch.dhtml, Identifier: CTR20131190.

24 April 2024 in Regenerative Therapy
Verified
Journal Article
Open access
QJQiang Jing
Qiang Jing
FLFan Liu
Fan Liu
WYWeitao Yao
Weitao Yao
HZHui Xu Zhang
Hui Xu Zhang
Diabetic ureteral injury (DUI) is a condition characterized by damage to the ureter, causing functional and morphological changes in the urinary system, which have a significant impact on a quality of life and requires appropriate medical treatment. The present study describes to novel design of luteolin (LT), a type of natural flavonoid, encapsulated selenium nanoparticles (Se NPs) to attain therapeutic potential for DUI. The physico-chemical characterizations of prepared Se NPs have benefitted zeta potential (-18 mV) and particle size (10-50 nm). In vitro assays were demonstrated the potential of LTSeNPs by HEK 293 cells stimulated by STZ for DUI. Cytotoxicity assays on HEK 293 and NIH-3T3 showed >90% cell viability, which demonstrates the suitability of the nanoformulation for DUI treatment. The LT-SeNPs significantly inhibits the NLRP3 inflammasome through Nrf2/ARE pathway, which benefits for DUI treatment. The developed LT-SeNPs could be an effective formulation for the DUI therapy.

28 June 2022 in Perioperative Medicine
Verified
Journal Article
Open access
PDF file
XYXiaobin Yuan
Xiaobin Yuan
LXLiu Xiaolei
Liu Xiaolei
QJQiang Jing
Qiang Jing
FLFan Liu
Fan Liu
HZHui Xu Zhang
Hui Xu Zhang
Background: In this study, it was aimed to evaluate the feasibility and effectiveness of full-size three-dimensional individual printed model (3D-IPM) based on computerized tomography (CT) reconstruction combined with 3D individual digital models (3D-IDMs) for improving the patient’s and their families’ comprehension levels of robotic-assisted laparoscopic partial nephrectomy (RALPN) preoperatively. Methods: Between January 2020 and January 2021, 37 patients underwent RALPN in our institution. 3D individual digital models (3D-IDMs) were reconstructed based on the data of computerized tomography (CT) scanning and full-size 3D-IPMs were fabricated correspondingly. For each patient and his/her closest accompanying immediate family member (CAIFM) (spouse or son/daughter), two semi-structured conversations were held by using CT films (1st conversation) and 3D-IPM combined with 3D-IDM demonstration (2nd one) respectively. The preoperative levels of comprehension were evaluated quantitatively by using a self-made preoperative comprehending score (PCS) in the patients and CAIFMs. Results: All the fabrications of full-size 3D-IPMs and all the operations were technically successful. The total PCS elevated significantly by presenting 3D-IPM combined with 3D-IDM demonstration compared with CT films (42.5 vs 35.5 in patients, P < 0.001; 42.9 vs 35.8 in CAIFMs, P < 0.001). Sub-PCSs in the evaluating aspects of renal anatomy, mass characteristics, the upcoming RALPN procedure, potential complication risks, and prognosis also showed a uniformed climbing pattern with the assistance of 3D-IPM+3D-IDM. Conclusion: The application of 3D-IPM presentation combined with 3D-IDM demonstration can improve the preoperative comprehension of patient and CAIFM to RALPN with more direct-viewing and verisimilar presentation, and can be used in RALPN patient education for increasing patients’ and their families’ cognitive empowerment.